Biomedica

InterValve Inc.

InterValve is dedicated to developing next generation aortic valvuloplasty balloon technologies for treatment of calcific aortic stenosis.
Balloon aortic valvuloplasty is a procedure for symptomatic patients who are not good candidates for surgery.

InterValve’s initial product, the V8, is the first aortic valvuloplasty balloon with an anatomical shape that maintains its waist throughout inflation in order to enhance safety and efficacy.

Link to InterValve Inc.

Back to list